Related Experiment Video

Updated: Dec 7, 2025

Organotypic Retinal Explant Cultures from Macaque Monkey
10:32

Organotypic Retinal Explant Cultures from Macaque Monkey

Published on: August 24, 2022

1.6K

Mechanisms of Photoreceptor Death in Retinitis Pigmentosa

Fay Newton1, Roly Megaw1,2

  • 1MRC Human Genetics Unit, University of Edinburgh, South Bridge, Edinburgh EH8 9YL, UK.

Genes
|September 29, 2020
PubMed

Insights

Retinitis pigmentosa (RP) causes inherited blindness through photoreceptor death. Understanding cell death pathways and immune responses is key to developing new RP treatments applicable to all mutations.

Area of Science:

  • Ophthalmology
  • Genetics
  • Immunology

Background:

  • Retinitis pigmentosa (RP) is a leading cause of inherited blindness, characterized by progressive retinal photoreceptor degeneration.
  • RP is genetically heterogeneous, necessitating treatments beyond gene-specific therapies.
  • Understanding photoreceptor death mechanisms is crucial for developing broad-spectrum RP treatments.

Purpose of the Study:

  • To review recent advancements in understanding rod and cone photoreceptor cell death in RP.
  • To explore the role of apoptotic and non-apoptotic pathways in RP pathogenesis.
  • To summarize current clinical trials targeting these cell death mechanisms.

Main Methods:

  • Literature review of recent studies on RP cell death mechanisms.
  • Analysis of research focusing on innate immune responses, particularly microglia, in RP progression.
  • Compilation of data from ongoing and completed clinical trials for RP.

Main Results:

  • Recent work highlights the involvement of both apoptotic and non-apoptotic cell death pathways in photoreceptor loss.
  • Emerging evidence implicates microglia and the innate immune system in driving RP progression.
  • Clinical trials are exploring various therapeutic strategies targeting these pathways.

Conclusions:

  • Developing treatments for RP requires a comprehensive understanding of diverse cell death mechanisms.
  • Targeting innate immune responses, especially microglial activation, presents a promising therapeutic avenue for RP.
  • Continued research and clinical trials are essential for effective RP management.
Keywords:
apoptosisautophagyclinical trialsinherited retinal diseasemicrogliaphotoreceptorregulated necrosisretinitis pigmentosa

More Related Videos

A Novel Light Damage Paradigm for Use in Retinal Regeneration Studies in Adult Zebrafish09:31

A Novel Light Damage Paradigm for Use in Retinal Regeneration Studies in Adult Zebrafish

Published on: October 24, 2013

10.7K
Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina09:05

Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina

Published on: May 6, 2015

11.2K

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.3K
The Retina01:32

The Retina

The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
73.7K